Abstract: Formulations for treating ocular surface diseases, such as dry eye disease, and related methods are disclosed. The formulations include and effective amount of ambroxol or a chemical derivative thereof (for example, bromhexine) that may be dispersed in a carrier and may optionally include a biocompatible polymer to provide extended release properties.

Abstract: This present application generally relates to methods and systems that allow for the establishment of personalized skin care regimen for an individual based upon the individual's genetic profile comprising biomarkers genetically associated with skin phenotypic attributes and/or skin nutritional conditions. In particular, kits and methods are disclosed for determining an individual's genetic profile, which may be used to select an appropriate therapeutic/dietary regimen or lifestyle recommendation based at least in part on the biomarkers used, weights applied thereto, and the resulting likelihood of the individual to exhibit a plurality of skin phenotypic attributes. Such a personalized skin care regimen is advantageous as compared to traditional skin care programs.

Abstract: Formulations for treating ocular surface diseases, such as dry eye disease, and related methods are disclosed. The formulations include and effective amount of ambroxol or a chemical derivative thereof (for example, bromhexine) that may be dispersed in a carrier and may optionally include a biocompatible polymer to provide extended release properties.

Abstract: Formulations for treating ocular surface diseases, such as dry eye disease, and related methods are disclosed. The formulations include and effective amount of ambroxol or a chemical derivative thereof (for example, bromhexine) that may be dispersed in a carrier and may optionally include a biocompatible polymer to provide extended release properties.

Abstract: Formulations for treating ocular surface diseases, such as dry eye disease, and related methods are disclosed. The formulations include ambroxol or a chemical derivative thereof (for example, ambroxol hydrochloride) dispersed in a carrier and may optionally include a biocompatible polymer to provide extended release properties.

Abstract: This present application generally relates to methods and systems that allow for the establishment of personalized skin care regimen for an individual based upon the individual's genetic profile comprising biomarkers genetically associated with skin phenotypic attributes and/or skin nutritional conditions. In particular, kits and methods are disclosed for determining an individual's genetic profile, which may be used to select an appropriate therapeutic/dietary regimen or lifestyle recommendation based at least in part on the biomarkers used, weights applied thereto, and the resulting likelihood of the individual to exhibit a plurality of skin phenotypic attributes. Such a personalized skin care regimen is advantageous as compared to traditional skin care programs.

Abstract: Formulations for treating ocular surface diseases, such as dry eye disease, and related methods are disclosed. The formulations include ambroxol or a chemical derivative thereof (for example, ambroxol hydrochloride) dispersed in a carrier and may optionally include a biocompatible polymer to provide extended release properties.

Abstract: Connector systems that may be easy to use, may be used to make connections in a limited area, may provide a stable and consistent connection, may provide good impedance matching, and may provide a good user experience. Various embodiments of the present invention may provide connector systems for conveying radio frequency (RF) signals.

Abstract: Dual mode genetics testing systems are devised about a single element testing platform. A microfluidic network and system of interconnected receiving cells and reaction vessels supports at the same time genotyping and copy number analysis where the platform may be subject to a common thermal cycle schedule to cause the proper reactions (DNA replication) necessary in both test types. Further, the microfluidic platform which includes reaction vessels for genotyping which are spatially removed from reaction vessels for copy number analysis, is coupled to optical scanner and detection systems specifically arranged to apply test specific detection routines on each of these distinct regions or portions of the dual mode test platform.

Abstract: The present inventions relates to methods and assays to predict the response of an individual to psychiatric treatment and to a method to improve medical treatment of a disorder, which responsive to treatment with a psychiatric treatment.

Abstract: Biological sample collection kits are devised with physical features to enable a high performance collection system which delivers preprocessed biological matter via conventional shipping means to a testing laboratories. In particular, untrained and unskilled users deposit biological matter such as saliva or blood into a receiving vessel. By sealing the container, the user causes release of a premixed solution containing preservatives and optionally lysis reagents. In addition, a purification agent is arranged to bind to target molecules and facilitate their removal from solution. These time consuming processes occur while the sample is in transit to the testing facility such that when it arrives, it is in a preconditioned state immediately ready for execution of washing steps.

Abstract: The present inventions relates to methods and assays to predict the response of an individual to an SSRI treatment and to a method to improve medical treatment of a disorder, which is responsive to treatment with a selective serotonin reuptake inhibitor (SSRI).

Abstract: The present inventions relates to methods and assays to predict the response of an individual to a psychiatric treatment and to a method to improve medical treatment of a disorder, which is responsive to treatment with a psychiatric treatment.

Abstract: The present inventions relates to methods and assays to predict the response of an individual to an SSRI treatment and to a method to improve medical treatment of a disorder, which is responsive to treatment with a selective serotonin reuptake inhibitor (SSRI).

Abstract: Dual mode genetics testing systems are devised about a single element testing platform. A microfluidic network and system of interconnected receiving cells and reaction vessels supports at the same time genotyping and copy number analysis where the platform may be subject to a common thermal cycle schedule to cause the proper reactions (DNA replication) necessary in both test types. Further, the microfluidic platform which includes reaction vessels for genotyping which are spatially removed from reaction vessels for copy number analysis, is coupled to optical scanner and detection systems specifically arranged to apply test specific detection routines on each of these distinct regions or portions of the dual mode test platform.

Abstract: The present inventions relates to methods and assays to predict the response of an individual to psychiatric treatment and to a method to improve medical treatment of a disorder, which responsive to treatment with a psychiatric treatment.

Abstract: Biological sample collection kits are devised with physical features to enable a high performance collection system which delivers preprocessed biological matter via conventional shipping means to a testing laboratories. In particular, untrained and unskilled users deposit biological matter such as saliva or blood into a receiving vessel. By sealing the container, the user causes release of a premixed solution containing preservatives and optionally lysis reagents. In addition, a purification agent is arranged to bind to target molecules and facilitate their removal from solution. These time consuming processes occur while the sample is in transit to the testing facility such that when it arrives, it is in a preconditioned state immediately ready for execution of washing steps.

Abstract: Dual mode genetics testing systems are devised about a single element testing platform. A microfluidic network and system of interconnected receiving cells and reaction vessels supports at the same time genotyping and copy number analysis where the platform may be subject to a common thermal cycle schedule to cause the proper reactions (DNA replication) necessary in both test types. Further, the microfluidic platform which includes reaction vessels for genotyping which are spatially removed from reaction vessels for copy number analysis, is coupled to optical scanner and detection systems specifically arranged to apply test specific detection routines on each of these distinct regions or portions of the dual mode test platform.

Abstract: A method for channel estimation of a signal, comprises the steps: estimating a channel response for pilot carriers of the signal; and estimating a channel response for non-pilot carriers of the signal as a function of the channel response for the pilot carriers of the signal and channel estimation coefficients for the pilot carriers, wherein a symbol of the signal is decoded as a function of the estimated channel response for the non-pilot carriers, and wherein certain ones of the channel estimation coefficients are updated as a function of the decoded symbol.

Abstract: A method for channel estimation of a signal, comprises the steps: estimating a channel response for pilot carriers of the signal; and estimating a channel response for non-pilot carriers of the signal as a function of the channel response for the pilot carriers of the signal and channel estimation coefficients for the pilot carriers, wherein a symbol of the signal is decoded as a function of the estimated channel response for the non-pilot carriers, and wherein certain ones of the channel estimation coefficients are updated as a function of the decoded symbol.